(Q74546253)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9586952%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

Comparison of the in vitro cytotoxicity of hydroxylamine metabolites of sulfamethoxazole and dapsone (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9586952%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9586952%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

T P Reilly

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9586952%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

F H Bellevue

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9586952%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

C K Svensson

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9586952%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

language of work or name

English

0 references

publication date

1 March 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9586952%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

published in

Biochemical Pharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9586952%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9586952%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9586952%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

803-810

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9586952%20AND%20SRC:MED&resulttype=core&format=json

Trimethoprim-sulphamethoxazole appears more effective than aerosolized pentamidine as secondary prophylaxis against Pneumocystis carinii pneumonia in patients with AIDS.

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900547-9

In vivo and in vitro testing for adverse drug reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900547-9

Adverse Reactions to Trimethoprim-Sulfamethoxazole in Patients with the Acquired Immunodeficiency Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900547-9

Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900547-9

Pneumocystis carinii Pneumonia: A Comparison Between Patients with the Acquired Immunodeficiency Syndrome and Patients with Other Immunodeficiencies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900547-9

Bioactivation and bioinactivation of drugs and drug metabolites: Relevance to adverse drug reactions

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900547-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900547-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900547-9

Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900547-9

Acetylation phenotype and cutaneous hypersensitivity to trimethoprim-sulphamethoxazole in HIV-infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900547-9

Sulfamethoxazole is metabolized to the hydroxylamine in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900547-9

Diagnosis of sulfonamide hypersensitivity reactions by in-vitro "rechallenge" with hydroxylamine metabolites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900547-9

In vitro cytotoxicity as a marker of hypersensitivity to sulphamethoxazole in patients with HIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900547-9

Time-course of toxicity of reactive sulfonamide metabolites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900547-9

Dapsone, trimethoprim, and sulfamethoxazole plasma levels during treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome (AIDS). Evidence of drug interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900547-9

Clinical pharmacokinetics of dapsone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900547-9

Agranulocytosis associated with malaria prophylaxis with Maloprim.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900547-9

The use of cimetidine as a selective inhibitor of dapsone N-hydroxylation in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900547-9

Formation and elimination of sulphamethoxazole hydroxylamine after oral administration of sulphamethoxazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900547-9

Adverse reactions to dapsone in persons infected with human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900547-9

Dapsone-induced hematologic toxicity: comparison of the methemoglobin-forming ability of hydroxylamine metabolites of dapsone in rat and human blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900547-9

Bioactivation of dapsone to a cytotoxic metabolite by human hepatic microsomal enzymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900547-9

Bioactivation of dapsone to a cytotoxic metabolite: in vitro use of a novel two compartment system which contains human tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900547-9

An investigation of the role of metabolism in dapsone-induced methaemoglobinaemia using a two compartment in vitro test system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900547-9

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900547-9

Applications of the MTT assay to functional studies of mouse intestinal intraepithelial lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900547-9

The use of a three compartment in vitro model to investigate the role of hepatic drug metabolism in drug-induced blood dyscrasias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900547-9

A rapid in vitro assay for evaluation of metabolism-dependent cytotoxicity of antiepileptic drugs on isolated human lymphocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900547-9

Cellular toxicity of sulfamethoxazole reactive metabolites--I. Inhibition of intracellular esterase activity prior to cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900547-9

Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900547-9

Dapsone toxicity: some current perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900547-9

Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro--II. Movement of dapsone across a semipermeable membrane into erythrocytes and plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900547-9

Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro. IV: Implications for the development of agranulocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900547-9

10.1016/S0006-2952(97)00547-9

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9586952%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference